Although SMA is typically considered a motor neuron disease, the ubiquitous nature of SMN production has prompted research into the effects of reduced levels of SMN in peripheral tissues and organs, in both patients and animal models of SMA. This evidence concerns the gene SMN1 and motor neuron disorder.